BioSpace News Archive

FDA

QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer

QIAGEN has announced the U.S. Food and Drug Administration approval of its therascreen® KRAS RGQ PCR kit as a companion diagnostic test to Mirati Therapeutic’s drug KRAZATI® for non-small cell lung cancer.

December 13, 2022
·
7 min read
Business

Soricimed Appoints Leading North American Cancer Researcher Dr. Siqing Fu to its Scientific Advisory Board

Soricimed Biopharma Inc., a clinical stage company focused on the development and commercialization of first-in-class targeted cancer therapeutics, has appointed Dr. Siqing Fu, a North American leader in cancer research, to its Scientific Advisory Board.

December 13, 2022
·
2 min read
Business

Sphere Fluidics Appoints Richard Hammond as Chief Technical Officer

Sphere Fluidics announced that it has appointed Richard Hammond as Chief Technical Officer.

December 13, 2022
·
2 min read
Business

West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announces that the Company’s Board of Directors has approved a first-quarter 2023 dividend of $0.19 per share.

December 13, 2022
·
1 min read
MediWound Expands Global Presence as NexoBrid® Gains Approval in India

MediWound Ltd., a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, announced it has gained marketing approval of NexoBrid® in India.

December 13, 2022
·
8 min read
Biotech Beach

Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that Health Canada has approved the company’s fourth-generation rechargeable sacral neuromodulation system.

December 13, 2022
·
3 min read
European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares

European Commission approves SPEVIGO ® (spesolimab) for generalized pustular psoriasis flares.

December 13, 2022
·
3 min read
Deals

AEON Biopharma to Become Publicly Listed via Merger with Priveterra Acquisition Corp.; Accelerating Clinical Development of ABP-450 (prabotulinumtoxinA) Injection to Treat Debilitating Medical Conditions in Neurology

AEON Biopharma, Inc. and Priveterra Acquisition Corp. announced that they have entered into a definitive business combination agreement.

December 13, 2022
·
11 min read
Biotech Bay

Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)-- Patents support Gritstone’s pioneering work in the application of next-generation samRNA vaccine technology in oncology and infectious disease --

Gritstone bio, Inc. today announced that the United States Patent and Trademark Office (USPTO) recently issued two new patents related to the company’s novel self-amplifying mRNA (samRNA) vaccine platform technology.

December 13, 2022
·
5 min read
Lone Star Bio

Marker Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for up to $25 Million

Marker Therapeutics, Inc. today announced that the Company has entered into a Common Stock Purchase Agreement (the “Agreement”) for up to $25 million with Lincoln Park Capital Fund (“LPC”).

December 13, 2022
·
5 min read